Search for content, post, videos

Oncoinvent opens new facilities


Yesterday, Oncoinvent held an opening ceremony for its new production and lab facilities.

The new production facility contains a Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin for upcoming preclinical and clinical studies.

“This event marks a highlight in a year that has seen tremendous growth in  the company.  The opening of our new laboratory and production facilities represents a significant achievement for the company and will enable the company to move Radspherin® rapidly into the next phase of development in 2018,” said Jan A. Alfheim, Oncoinvent’s CEO.